Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

Environmental and chemical exposures have emerged as critical contributors to the global cancer burden. Sources such as dietary contaminants, food ...

AI-powered health collaboration targets African precision medicine By Staff Writer, ITWebJohannesburg, 12 Dec 2025The partnership will boost integrated multiome data analysis and AI-driven insights.

Thierry Nordmann was on his first night shift as a dermatologist at University Hospital Basel, Switzerland, when he got the emergency call. A patient was being brought in who’d had a severe reaction ...

n this study, 773 untreated breast cancer patients from all over China were collected and followed up for at least 5 years. We obtained clinical data from 773 cases, RNA sequencing data from 752 cases ...

Proteogenomics and their applications in target cancer therapy research. The application of proteogenomics (mainly including genomics, transcriptomics, and proteomics) has become an indispensable tool ...

Background Most patients with biliary tract cancer (BTC) do not derive durable clinical benefit (DCB) from immune checkpoint inhibitors (ICIs), underscoring the urgent need for predictive biomarkers.

Olink, part of Thermo Fisher Scientific, together with Psomagen, is excited to invite you to an expert panel discussion exploring how protein biomarkers are reshaping the future of oncology research.

Exploring biology in its native environment is perhaps the ideal scenario for generating better hypotheses about the cellular interactions that influence—and drive—healthy and diseased states, ...